Search Count: 68
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-08-13 Classification: STRUCTURAL PROTEIN/INHIBITOR Ligands: A1BW7 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-08-13 Classification: STRUCTURAL PROTEIN/INHIBITOR Ligands: A1BW8 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-08-13 Classification: STRUCTURAL PROTEIN/INHIBITOR Ligands: A1BW9 |
 |
Crystal Structure Of Hck In Complex With The Src-Family Kinase Inhibitor A-419259
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-10-09 Classification: TRANSFERASE Ligands: VSE, EDO, DMS, SCN |
 |
Organism: Hiv-1 m:b_arv2/sf2, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.63 Å Release Date: 2023-02-22 Classification: VIRAL PROTEIN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2022-12-28 Classification: TRANSFERASE Ligands: GOL, VSE, CL, PO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.99 Å Release Date: 2022-12-28 Classification: TRANSFERASE Ligands: OJL, EDO, GOL, PO4 |
 |
Discovery Of Potent Orally Bioavailable Wd Repeat Domain 5 (Wdr5) Inhibitors Using A Pharmacophore-Based Optimization
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2022-05-04 Classification: Transcription/Transcription Inhibitor Ligands: MBU |
 |
Wdr5 Bound To 2-(3,5-Dimethoxybenzyl)-7-((2-Methyl-1H-Imidazol-1-Yl)Methyl)-5-(1-Methyl-3-(Trifluoromethyl)-1H-Pyrazol-4-Yl)-3,4-Dihydroisoquinolin-1(2H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2022-04-27 Classification: Transcription/Transcription Inhibitor Ligands: BEN, M4U |
 |
Sars-Cov-2 3Clpro In Complex With 2-(Benzotriazol-1-Yl)-N-[4-(1H-Pyrazol-4-Yl)Phenyl]-N-(3-Thienylmethyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, hydrolase/Inhibitor Ligands: Y6A |
 |
Sars-Cov-2 3Clpro In Complex With N-[4-[[2-(Benzotriazol-1-Yl)Acetyl]-(3-Thienylmethyl)Amino]Phenyl]Cyclopropanecarboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: Y6J |
 |
Sars-Cov-2 3Clpro In Complex With 2-(Benzotriazol-1-Yl)-N-[4-(1H-Imidazol-4-Yl)Phenyl]-N-(3-Thienylmethyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: Y6G |
 |
Sars-Cov-1 3Clpro In Complex With N-(4-(1H-Imidazol-4-Yl)Phenyl)-2-(1H-Benzo[D][1,2,3]Triazol-1-Yl)-N-(Thiophen-3-Ylmethyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: GOL, Y6G, PEG |
 |
Sars-Cov-1 3Clpro In Complex With 2-(1H-Benzo[D][1,2,3]Triazol-1-Yl)-N-(4-(Pyridin-3-Yl)Phenyl)-N-(Thiophen-3-Ylmethyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: Y6D, GOL |
 |
Sars-Cov-1 3Clpro In Complex With N-(4-(1H-Pyrazol-4-Yl)Phenyl)-2-(1H-Benzo[D][1,2,3]Triazol-1-Yl)-N-(Thiophen-3-Ylmethyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.71 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: GOL, Y6A |
 |
Sars-Cov-1 3Clpro In Complex With 2-(1H-Benzo[D][1,2,3]Triazol-1-Yl)-N-(3-Chlorobenzyl)-N-(4-(2-Oxo-1,2-Dihydropyridin-3-Yl)Phenyl)Acetamide
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2021-08-11 Classification: VIRAL PROTEIN, Hydrolase/Inhibitor Ligands: PEG, GOL, Y67 |
 |
Discovery And Structure-Based Optimization Of Potent And Selective Wdr5 Inhibitors Containing A Dihydroisoquinolinone Bicyclic Core
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2020-01-01 Classification: TRANSCRIPTION Ligands: Q41 |
 |
Wd Repeat-Containing Protein 5 Complexed With N-[(3,5-Dimethoxyphenyl)Methyl]-4'-Fluoro-5-{[(2E)-2-Imino-3-Methyl-2,3-Dihydro-1H-Imidazol-1-Yl]Methyl}-2'-Methyl[1,1'-Biphenyl]-3-Carboxamide (Compound 13)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2020-01-01 Classification: GENE REGULATION/INHIBITOR Ligands: Q6S |
 |
Discovery And Optimization Of Salicyclic Acid-Derived Sulfonamide Inhibitors Of The Wdr5:Myc Protein-Protein Interaction
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2019-12-04 Classification: TRANSCRIPTION Ligands: Q0S |
 |
Discovery And Optimization Of Salicyclic Acid-Derived Sulfonamide Inhibitors Of The Wdr5:Myc Protein-Protein Interaction
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2019-12-04 Classification: TRANSCRIPTION Ligands: Q0M |